Identification of New Dystroglycan Complexes in Skeletal Muscle

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Johnson, Eric K ^a   Li, Bin ^b   Yoon, Jung Hae ^a   Flanigan, Kevin M ^a,c   Martin, Paul T ^a,c   Ervasti, James ^b   Montanaro, Federica ^a,c  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DYSTROGLYCAN; DYSTROGLYCAN COMPLEX; DYSTROPHIN; MUSCLE PROTEIN; UNCLASSIFIED DRUG; UTROPHIN;

ANIMAL TISSUE; ARTICLE; BIOCHEMICAL COMPOSITION; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; HUMAN; HUMAN TISSUE; MOUSE; NEUROMUSCULAR SYNAPSE; NONHUMAN; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; UPREGULATION; WILD TYPE;

ANIMALS; DYSTROGLYCANS; DYSTROPHIN; GENE DELETION; HUMANS; MICE; MICE, INBRED C57BL; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; PROTEIN INTERACTION MAPS; SYNAPSES; UTROPHIN;

EID: 84881347420     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0073224     Document Type: Article

References (93)

1. Ibraghimov-Beskrovnaya O, Ervasti JM, Leveille CJ, Slaughter CA, Sernett SW, et al. (1992) Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 355: 696-702. doi:10.1038/355696a0. PubMed: 1741056.
2. Yoshida M, Suzuki A, Yamamoto H, Noguchi S, Mizuno Y, et al. (1994) Dissociation of the complex of dystrophin and its associated proteins into several unique groups by n-octyl beta-D-glucoside. Eur J Biochem 222: 1055-1061. doi:10.1111/j.1432-1033.1994.tb18958.x. PubMed: 8026484.
3. Campbell KP, Kahl SD, (1989) Association of dystrophin and an integral membrane glycoprotein. Nature 338: 259-262. doi:10.1038/338259a0. PubMed: 2493582.
4. Suzuki A, Yoshida M, Yamamoto H, Ozawa E, (1992) Glycoprotein-binding site of dystrophin is confined to the cysteine-rich domain and the first half of the carboxy-terminal domain. FEBS Lett 308: 154-160. doi:10.1016/0014-5793(92)81265-N. PubMed: 1499724.
5. Ervasti JM, Campbell KP, (1993) A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol 122: 809-823. doi:10.1083/jcb.122.4.809. PubMed: 8349731.
6. Gee SH, Blacher RW, Douville PJ, Provost PR, Yurchenco PD, et al. (1993) Laminin-binding protein 120 from brain is closely related to the dystrophin-associated glycoprotein, dystroglycan, and binds with high affinity to the major heparin binding domain of laminin. J Biol Chem 268: 14972-14980. PubMed: 8325873.
7. Jung D, Yang B, Meyer J, Chamberlain JS, Campbell KP, (1995) Identification and characterization of the dystrophin anchoring site on beta-dystroglycan. J Biol Chem 270: 27305-27310. doi:10.1074/jbc.270.45.27305. PubMed: 7592992.
8. Corrado K, Mills PL, Chamberlain JS, (1994) Deletion analysis of the dystrophin-actin binding domain. FEBS Lett 344: 255-260. doi:10.1016/0014-5793(94)00397-1. PubMed: 8187894.
9. Hoffman EP, Brown RH Jr., Kunkel LM, (1987) Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51: 919-928. doi:10.1016/0092-8674(87)90579-4. PubMed: 3319190.
10. Bonilla E, Samitt CE, Miranda AF, Hays AP, Salviati G, et al. (1988) Duchenne muscular dystrophy: deficiency of dystrophin at the muscle cell surface. Cell 54: 447-452. doi:10.1016/0092-8674(88)90065-7. PubMed: 3042151.
11. Brockington M, Blake DJ, Prandini P, Brown SC, Torelli S, et al. (2001) Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan. Am J Hum Genet 69: 1198-1209. doi:10.1086/324412. PubMed: 11592034.
12. Longman C, Brockington M, Torelli S, Jimenez-Mallebrera C, Kennedy C, et al. (2003) Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan. Hum Mol Genet 12: 2853-2861. doi:10.1093/hmg/ddg307. PubMed: 12966029.
13. Sabatelli P, Columbaro M, Mura I, Capanni C, Lattanzi G, et al. (2003) Extracellular matrix and nuclear abnormalities in skeletal muscle of a patient with Walker-Warburg syndrome caused by POMT1 mutation. Biochim Biophys Acta 1638: 57-62. doi:10.1016/S0925-4439(03)00040-1. PubMed: 12757935.
14. Michele DE, Barresi R, Kanagawa M, Saito F, Cohn RD, et al. (2002) Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Nature 418: 417-422. doi:10.1038/nature00837. PubMed: 12140558.
15. Miller G, Moore CJ, Terry R, La Riviere T, Mitchell A, et al. (2012) Preventing phosphorylation of dystroglycan ameliorates the dystrophic phenotype in mdx mouse. Hum Mol Genet 21: 4508-4520. doi:10.1093/hmg/dds293. PubMed: 22810924.
16. Rafael JA, Cox GA, Corrado K, Jung D, Campbell KP, et al. (1996) Forced expression of dystrophin deletion constructs reveals structure-function correlations. J Cell Biol 134: 93-102. doi:10.1083/jcb.134.1.93. PubMed: 8698825.
17. Rafael JA, Sunada Y, Cole NM, Campbell KP, Faulkner JA, et al. (1994) Prevention of dystrophic pathology in mdx mice by a truncated dystrophin isoform. Hum Mol Genet 3: 1725-1733. doi:10.1093/hmg/3.10.1725. PubMed: 7849695.
18. Takemitsu M, Ishiura S, Koga R, Kamakura K, Arahata K, et al. (1991) Dystrophin-related protein in the fetal and denervated skeletal muscles of normal and mdx mice. Biochem Biophys Res Commun 180: 1179-1186. doi:10.1016/S0006-291X(05)81320-8. PubMed: 1953770.
19. Bewick GS, Nicholson LV, Young C, O'Donnell E, Slater CR, (1992) Different distributions of dystrophin and related proteins at nerve-muscle junctions. Neuroreport 3: 857-860. doi:10.1097/00001756-199210000-00009. PubMed: 1421088.
20. Bewick GS, Nicholson LV, Young C, Slater CR, (1993) Relationship of a dystrophin-associated glycoprotein to junctional acetylcholine receptor clusters in rat skeletal muscle. Neuromuscul Disord 3: 503-506. doi:10.1016/0960-8966(93)90105-S. PubMed: 8186701.
21. Bartoli M, Ramarao MK, Cohen JB, (2001) Interactions of the rapsyn RING-H2 domain with dystroglycan. J Biol Chem 276: 24911-24917. doi:10.1074/jbc.M103258200. PubMed: 11342559.
22. Montanaro F, Gee SH, Jacobson C, Lindenbaum MH, Froehner SC, et al. (1998) Laminin and alpha-dystroglycan mediate acetylcholine receptor aggregation via a MuSK-independent pathway. J Neurosci 18: 1250-1260. PubMed: 9454835.
23. Jacobson C, Montanaro F, Lindenbaum M, Carbonetto S, Ferns M, (1998) alpha-Dystroglycan functions in acetylcholine receptor aggregation but is not a coreceptor for agrin-MuSK signaling. J Neurosci 18: 6340-6348. PubMed: 9698325.
24. Tanaka H, Ishiguro T, Eguchi C, Saito K, Ozawa E, (1991) Expression of a dystrophin-related protein associated with the skeletal muscle cell membrane. Histochemistry 96: 1-5. doi:10.1007/BF00266753. PubMed: 1938476.
25. Shim JY, Kim TS, (2003) Relationship between utrophin and regenerating muscle fibers in duchenne muscular dystrophy. Yonsei Med J 44: 15-23. PubMed: 12619170.
26. Ohlendieck K, Ervasti JM, Matsumura K, Kahl SD, Leveille CJ, et al. (1991) Dystrophin-related protein is localized to neuromuscular junctions of adult skeletal muscle. Neuron 7: 499-508. doi:10.1016/0896-6273(91)90301-F. PubMed: 1654951.
27. Rybakova IN, Patel JR, Ervasti JM, (2000) The dystrophin complex forms a mechanically strong link between the sarcolemma and costameric actin. J Cell Biol 150: 1209-1214. doi:10.1083/jcb.150.5.1209. PubMed: 10974007.
28. Deconinck AE, Rafael JA, Skinner JA, Brown SC, Potter AC, et al. (1997) Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy. Cell 90: 717-727. doi:10.1016/S0092-8674(00)80532-2. PubMed: 9288751.
29. Deconinck N, Rafael JA, Beckers-Bleukx G, Kahn D, Deconinck AE, et al. (1998) Consequences of the combined deficiency in dystrophin and utrophin on the mechanical properties and myosin composition of some limb and respiratory muscles of the mouse. Neuromuscul Disord 8: 362-370. doi:10.1016/S0960-8966(98)00048-0. PubMed: 9713852.
30. Johnson EK, Zhang L, Adams ME, Phillips A, Freitas MA, et al. (2012) Proteomic analysis reveals new cardiac-specific dystrophin-associated proteins. PLOS ONE 7: e43515. doi:10.1371/journal.pone.0043515. PubMed: 22937058.
31. Yoon JH, Johnson E, Xu R, Martin LT, Martin PT, et al. (2012) Comparative Proteomic Profiling of Dystroglycan-Associated Proteins in Wild Type, mdx, and Galgt2 Transgenic Mouse Skeletal Muscle. J Proteome Res 11: 4413-4424. doi:10.1021/pr300328r. PubMed: 22775139.
32. Ohlendieck K, Ervasti JM, Snook JB, Campbell KP, (1991) Dystrophin-glycoprotein complex is highly enriched in isolated skeletal muscle sarcolemma. J Cell Biol 112: 135-148. doi:10.1083/jcb.112.1.135. PubMed: 1986002.
33. Yamada H, Shimizu T, Tanaka T, Campbell KP, Matsumura K, (1994) Dystroglycan is a binding protein of laminin and merosin in peripheral nerve. FEBS Lett 352: 49-53. doi:10.1016/0014-5793(94)00917-1. PubMed: 7925941.
34. Yamada H, Denzer AJ, Hori H, Tanaka T, Anderson LV, et al. (1996) Dystroglycan is a dual receptor for agrin and laminin-2 in Schwann cell membrane. J Biol Chem 271: 23418-23423. doi:10.1074/jbc.271.38.23418. PubMed: 8798547.
35. Shimizu H, Hosokawa H, Ninomiya H, Miner JH, Masaki T, (1999) Adhesion of cultured bovine aortic endothelial cells to laminin-1 mediated by dystroglycan. J Biol Chem 274: 11995-12000. doi:10.1074/jbc.274.17.11995. PubMed: 10207021.
36. Hosokawa H, Ninomiya H, Kitamura Y, Fujiwara K, Masaki T, (2002) Vascular endothelial cells that express dystroglycan are involved in angiogenesis. J Cell Sci 115: 1487-1496. PubMed: 11896196.
37. Tadayoni R, Rendon A, Soria-Jasso LE, Cisneros B, (2011) Dystrophin Dp71: The Smallest but Multifunctional Product of the Duchenne Muscular Dystrophy Gene. Mol: Neurobiol.
38. Singhal N, Xu R, Martin PT, (2012) Distinct contributions of Galgt1 and Galgt2 to carbohydrate expression and function at the mouse neuromuscular junction. Mol Cell Neurosci 51: 112-126. doi:10.1016/j.mcn.2012.08.014. PubMed: 22982027.
39. Jarad G, Miner JH, (2009) The Pax3-Cre transgene exhibits a rostrocaudal gradient of expression in the skeletal muscle lineage. Genesis 47: 1-6. doi:10.1002/dvg.20447. PubMed: 18942111.
40. Peters MF, Adams ME, Froehner SC, (1997) Differential association of syntrophin pairs with the dystrophin complex. J Cell Biol 138: 81-93. doi:10.1083/jcb.138.1.81. PubMed: 9214383.
41. Peters MF, Sadoulet-Puccio HM, Grady MR, Kramarcy NR, Kunkel LM, et al. (1998) Differential membrane localization and intermolecular associations of alpha-dystrobrevin isoforms in skeletal muscle. J Cell Biol 142: 1269-1278. doi:10.1083/jcb.142.5.1269. PubMed: 9732287.
42. Crawford GE, Faulkner JA, Crosbie RH, Campbell KP, Froehner SC, et al. (2000) Assembly of the dystrophin-associated protein complex does not require the dystrophin COOH-terminal domain. J Cell Biol 150: 1399-1410. doi:10.1083/jcb.150.6.1399. PubMed: 10995444.
43. Peters MF, Kramarcy NR, Sealock R, Froehner SC, (1994) beta 2-Syntrophin: localization at the neuromuscular junction in skeletal muscle. Neuroreport 5: 1577-1580. doi:10.1097/00001756-199408150-00009. PubMed: 7819523.
44. Matsumura K, Ervasti JM, Ohlendieck K, Kahl SD, Campbell KP, (1992) Association of dystrophin-related protein with dystrophin-associated proteins in mdx mouse muscle. Nature 360: 588-591. doi:10.1038/360588a0. PubMed: 1461282.
45. Collet C, Csernoch L, Jacquemond V, (2003) Intramembrane charge movement and L-type calcium current in skeletal muscle fibers isolated from control and mdx mice. Biophys J 84: 251-265. doi:10.1016/S0006-3495(03)74846-2. PubMed: 12524279.
46. Johnson BD, Scheuer T, Catterall WA, (2005) Convergent regulation of skeletal muscle Ca2+ channels by dystrophin, the actin cytoskeleton, and cAMP-dependent protein kinase. Proc Natl Acad Sci U S A 102: 4191-4196. doi:10.1073/pnas.0409695102. PubMed: 15753322.
47. Buraei Z, Yang J, (2012) Structure and function of the beta subunit of voltage-gated Ca(2+) channels. Biochim Biophys Acta.
48. Ervasti JM, Campbell KP, (1991) Membrane organization of the dystrophin-glycoprotein complex. Cell 66: 1121-1131. doi:10.1016/0092-8674(91)90035-W. PubMed: 1913804.
49. Stalnaker SH, Hashmi S, Lim JM, Aoki K, Porterfield M, et al. (2010) Site mapping and characterization of O-glycan structures on alpha-dystroglycan isolated from rabbit skeletal muscle. J Biol Chem 285: 24882-24891. doi:10.1074/jbc.M110.126474. PubMed: 20507986.
50. Holt KH, Lim LE, Straub V, Venzke DP, Duclos F, et al. (1998) Functional rescue of the sarcoglycan complex in the BIO 14.6 hamster using delta-sarcoglycan gene transfer. Mol Cell 1: 841-848. doi:10.1016/S1097-2765(00)80083-0. PubMed: 9660967.
51. Durbeej M, Cohn RD, Hrstka RF, Moore SA, Allamand V, et al. (2000) Disruption of the beta-sarcoglycan gene reveals pathogenetic complexity of limb-girdle muscular dystrophy type 2E. Mol Cell 5: 141-151.
52. Straub V, Duclos F, Venzke DP, Lee JC, Cutshall S, et al. (1998) Molecular pathogenesis of muscle degeneration in the delta-sarcoglycan-deficient hamster. Am J Pathol 153: 1623-1630. doi:10.1016/S0002-9440(10)65751-3. PubMed: 9811355.
53. Crosbie RH, Lebakken CS, Holt KH, Venzke DP, Straub V, et al. (1999) Membrane targeting and stabilization of sarcospan is mediated by the sarcoglycan subcomplex. J Cell Biol 145: 153-165. doi:10.1083/jcb.145.1.153. PubMed: 10189375.
54. Sotgia F, Lee JK, Das K, Bedford M, Petrucci TC, et al. (2000) Caveolin-3 directly interacts with the C-terminal tail of beta-dystroglycan. Identification of a central WW-like domain within caveolin family members. J Biol Chem 275: 38048-38058. doi:10.1074/jbc.M005321200. PubMed: 10988290.
55. Russo K, Di Stasio E, Macchia G, Rosa G, Brancaccio A, et al. (2000) Characterization of the beta-dystroglycan-growth factor receptor 2 (Grb2) interaction. Biochem Biophys Res Commun 274: 93-98. doi:10.1006/bbrc.2000.3103. PubMed: 10903901.
56. Sotgia F, Lee H, Bedford MT, Petrucci T, Sudol M, et al. (2001) Tyrosine phosphorylation of beta-dystroglycan at its WW domain binding motif, PPxY, recruits SH2 domain containing proteins. Biochemistry 40: 14585-14592. doi:10.1021/bi011247r. PubMed: 11724572.
57. Poulton JS, Deng WM, (2006) Dystroglycan down-regulation links EGF receptor signaling and anterior-posterior polarity formation in the Drosophila oocyte. Proc Natl Acad Sci U S A 103: 12775-12780. doi:10.1073/pnas.0603817103. PubMed: 16908845.
58. Guadagno E, Moukhles H, (2004) Laminin-induced aggregation of the inwardly rectifying potassium channel, Kir4.1, and the water-permeable channel, AQP4, via a dystroglycan-containing complex in astrocytes. Glia 47: 138-149. doi:10.1002/glia.20039. PubMed: 15185393.
59. Sirour C, Hidalgo M, Bello V, Buisson N, Darribère T, et al. (2011) Dystroglycan is involved in skin morphogenesis downstream of the Notch signaling pathway. Mol Biol Cell 22: 2957-2969. doi:10.1091/mbc.E11-01-0074. PubMed: 21680717.
60. Occhi S, Zambroni D, Del Carro U, Amadio S, Sirkowski EE, et al. (2005) Both laminin and Schwann cell dystroglycan are necessary for proper clustering of sodium channels at nodes of ranvier. J Neurosci 25: 9418-9427. doi:10.1523/JNEUROSCI.2068-05.2005. PubMed: 16221851.
61. Noël G, Belda M, Guadagno E, Micoud J, Klöcker N, et al. (2005) Dystroglycan and Kir4.1 coclustering in retinal Muller glia is regulated by laminin-1 and requires the PDZ-ligand domain of Kir4.1. J Neurochem 94: 691-702. doi:10.1111/j.1471-4159.2005.03191.x. PubMed: 16033419.
62. Saito F, Moore SA, Barresi R, Henry MD, Messing A, et al. (2003) Unique role of dystroglycan in peripheral nerve myelination, nodal structure, and sodium channel stabilization. Neuron 38: 747-758. doi:10.1016/S0896-6273(03)00301-5. PubMed: 12797959.
63. Galvin J, Eyermann C, Colognato H, (2010) Dystroglycan modulates the ability of insulin-like growth factor-1 to promote oligodendrocyte differentiation. J Neurosci Res 88: 3295-3307. doi:10.1002/jnr.22484. PubMed: 20857503.
64. Masuda-Hirata M, Suzuki A, Amano Y, Yamashita K, Ide M, et al. (2009) Intracellular polarity protein PAR-1 regulates extracellular laminin assembly by regulating the dystroglycan complex. Genes Cells 14: 835-850. doi:10.1111/j.1365-2443.2009.01315.x. PubMed: 19549170.
65. Batchelor CL, Higginson JR, Chen YJ, Vanni C, Eva A, et al. (2007) Recruitment of Dbl by ezrin and dystroglycan drives membrane proximal Cdc42 activation and filopodia formation. Cell Cycle 6: 353-363. doi:10.4161/cc.6.3.3819. PubMed: 17297291.
66. Zhan Y, Tremblay MR, Melian N, Carbonetto S, (2005) Evidence that dystroglycan is associated with dynamin and regulates endocytosis. J Biol Chem 280: 18015-18024. PubMed: 15728588.
67. Ayalon G, Davis JQ, Scotland PB, Bennett V, (2008) An ankyrin-based mechanism for functional organization of dystrophin and dystroglycan. Cell 135: 1189-1200. doi:10.1016/j.cell.2008.10.018. PubMed: 19109891.
68. Rezniczek GA, Konieczny P, Nikolic B, Reipert S, Schneller D, et al. (2007) Plectin 1f scaffolding at the sarcolemma of dystrophic (mdx) muscle fibers through multiple interactions with {beta}-dystroglycan. J Cell Biol 176: 965-977. doi:10.1083/jcb.200604179. PubMed: 17389230.
69. Prins KW, Humston JL, Mehta A, Tate V, Ralston E, et al. (2009) Dystrophin is a microtubule-associated protein. J Cell Biol 186: 363-369. doi:10.1083/jcb.200905048. PubMed: 19651889.
70. Cluchague N, Moreau C, Rocher C, Pottier S, Leray G, et al. (2004) beta-Dystroglycan can be revealed in microsomes from mdx mouse muscle by detergent treatment. FEBS Lett 572: 216-220. doi:10.1016/j.febslet.2004.07.032. PubMed: 15304351.
71. Montanaro F, Lindenbaum M, Carbonetto S, (1999) alpha-Dystroglycan is a laminin receptor involved in extracellular matrix assembly on myotubes and muscle cell viability. J Cell Biol 145: 1325-1340. doi:10.1083/jcb.145.6.1325. PubMed: 10366602.
72. Tremblay MR, Carbonetto S, (2006) An extracellular pathway for dystroglycan function in acetylcholine receptor aggregation and laminin deposition in skeletal myotubes. J Biol Chem, 281: 13365-73: M600912200 PubMed: 16531403.
73. Bowe MA, Mendis DB, Fallon JR, (2000) The small leucine-rich repeat proteoglycan biglycan binds to alpha-dystroglycan and is upregulated in dystrophic muscle. J Cell Biol 148: 801-810. doi:10.1083/jcb.148.4.801. PubMed: 10684260.
74. Hill MM, Bastiani M, Luetterforst R, Kirkham M, Kirkham A, et al. (2008) PTRF-Cavin, a conserved cytoplasmic protein required for Caveola formation and function. Cell 132: 113-124. doi:10.1016/j.cell.2007.11.042. PubMed: 18191225.
75. Zhu H, Lin P, De G, Choi KH, Takeshima H, et al. (2011) Polymerase transcriptase release factor (PTRF) anchors MG53 protein to cell injury site for initiation of membrane repair. J Biol Chem 286: 12820-12824. doi:10.1074/jbc.C111.221440. PubMed: 21343302.
76. Bansal D, Miyake K, Vogel SS, Groh S, Chen CC, et al. (2003) Defective membrane repair in dysferlin-deficient muscular dystrophy. Nature 423: 168-172. doi:10.1038/nature01573. PubMed: 12736685.
77. Repetto S, Bado M, Broda P, Lucania G, Masetti E, et al. (1999) Increased number of caveolae and caveolin-3 overexpression in Duchenne muscular dystrophy. Biochem Biophys Res Commun 261: 547-550. doi:10.1006/bbrc.1999.1055. PubMed: 10441463.
78. Shibuya S, Wakayama Y, Inoue M, Oniki H, Kominami E, (2002) Changes in the distribution and density of caveolin 3 molecules at the plasma membrane of mdx mouse skeletal muscles: a fracture-label electron microscopic study. Neurosci Lett 325: 171-174. doi:10.1016/S0304-3940(02)00267-7. PubMed: 12044648.
79. Sharma P, Ghavami S, Stelmack GL, McNeill KD, Mutawe MM, et al. (2010) beta-Dystroglycan binds caveolin-1 in smooth muscle: a functional role in caveolae distribution and Ca2+ release. J Cell Sci 123: 3061-3070. doi:10.1242/jcs.066712. PubMed: 20736308.
80. Péréon Y, Dettbarn C, Navarro J, Noireaud J, Palade PT, (1997) Dihydropyridine receptor gene expression in skeletal muscle from mdx and control mice. Biochim Biophys Acta 1362: 201-207. doi:10.1016/S0925-4439(97)00079-3. PubMed: 9540851.
81. Godfrey C, Foley AR, Clement E, Muntoni F, (2011) Dystroglycanopathies: coming into focus. Curr Opin Genet Dev 21: 278-285. doi:10.1016/j.gde.2011.02.001. PubMed: 21397493.
82. Yang B, Jung D, Motto D, Meyer J, Koretzky G, et al. (1995) SH3 domain-mediated interaction of dystroglycan and Grb2. J Biol Chem 270: 11711-11714. doi:10.1074/jbc.270.20.11711. PubMed: 7744812.
83. Xiong Y, Zhou Y, Jarrett HW, (2009) Dystrophin glycoprotein complex-associated Gbetagamma subunits activate phosphatidylinositol-3-kinase/Akt signaling in skeletal muscle in a laminin-dependent manner. J Cell Physiol 219: 402-414. doi:10.1002/jcp.21684. PubMed: 19117013.
84. Moore CJ, Winder SJ, (2010) Dystroglycan versatility in cell adhesion: a tale of multiple motifs. Cell Commun Signal 8: 3. doi:10.1186/1478-811X-8-3. PubMed: 20163697.
85. Cartaud A, Coutant S, Petrucci TC, Cartaud J, (1998) Evidence for in situ and in vitro association between beta-dystroglycan and the subsynaptic 43K rapsyn protein. Consequence for acetylcholine receptor clustering at the synapse. J Biol Chem 273: 11321-11326. doi:10.1074/jbc.273.18.11321. PubMed: 9556625.
86. Li D, Bareja A, Judge L, Yue Y, Lai Y, et al. (2010) Sarcolemmal nNOS anchoring reveals a qualitative difference between dystrophin and utrophin. J Cell Sci 123: 2008-2013. doi:10.1242/jcs.064808. PubMed: 20483958.
87. Muntoni F, Torelli S, Wells DJ, Brown SC, (2011) Muscular dystrophies due to glycosylation defects: diagnosis and therapeutic strategies. Curr Opin Neurol 24: 437-442. doi:10.1097/WCO.0b013e32834a95e3. PubMed: 21825985.
88. Chandrasekharan K, Martin PT, (2010) Genetic defects in muscular dystrophy. Methods Enzymol 479: 291-322. doi:10.1016/S0076-6879(10)79017-0. PubMed: 20816173.
89. Dubowitz V, Sewry CA, Fitzsimons RB, (1985) Muscle biopsy: a practical approach. Eastbourne: Baillière Tindall. 520pp.
90. Combs AC, Ervasti JM, (2005) Enhanced laminin binding by alpha-dystroglycan after enzymatic deglycosylation. Biochem J 390: 303-309. doi:10.1042/BJ20050375. PubMed: 15865602.
91. Rybakova IN, Humston JL, Sonnemann KJ, Ervasti JM, (2006) Dystrophin and Utrophin Bind Actin through Distinct Modes of Contact. J Biol Chem 281: 9996-10001. doi:10.1074/jbc.M513121200. PubMed: 16478721.
92. Elias JE, Gygi SP, (2007) Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat Methods 4: 207-214. doi:10.1038/nmeth1019. PubMed: 17327847.
93. Elias JE, Gygi SP, (2010) Target-decoy search strategy for mass spectrometry-based proteomics. Methods Mol Biol 604: 55-71. doi:10.1007/978-1-60761-444-9_5. PubMed: 20013364.